Metraipolis › archive › dc_5c2bac6a2fef

The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41373685
DOI
10.3390/ijms262311534
License (as archived)
solo-consultazione
Archived
2026-11-08T04:14:10.663Z
SHA-256 of the archived text
d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895
Stable URL of this page
https://metraipolis.com/documento/dc_5c2bac6a2fef

How to cite

The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685 — Europe PMC (en), https://europepmc.org/article/MED/41373685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c2bac6a2fef (Metraipolis archive dc_5c2bac6a2fef, sha256 d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895)
BibTeX
@misc{dc5c2bac6a2fef,
  title = {The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41373685},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c2bac6a2fef; sha256 d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41373685. Agents can read the archived copy with the MCP tool read_document.